Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center.
D000380:Agranulocytosis / Q000150:complications; D002228:Carbenicillin / Q000494:pharmacology / Q000627:therapeutic use*; D002512:Cephalothin / Q000494:pharmacology / Q000627:therapeutic use; D004338:Drug Combinations; D004755:Enterobacteriaceae / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D005839:Gentamicins / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D010403:Penicillin Resistance; D011513:Proteus mirabilis / Q000187:drug effects; D011552:Pseudomonas Infections / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D012703:Serotyping; D012706:Serratia marcescens / Q000187:drug effects; D014774:Virulence / Q000187:drug effects
D004338:Drug Combinations; D005839:Gentamicins; D002228:Carbenicillin; D002512:Cephalothin